Preclinical data demonstrated strong activity of KYV-101 derived from patients with lupus, a key prerequisite for positive outcomes Research conducted in partnership with University of Erlangen Data to be presented in poster session and industry-sponsored symposium about CAR T-cell…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.